Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Upstream Bio (UPB) Gross Profit (2024 - 2025)

Upstream Bio (UPB) has 2 years of Gross Profit data on record, last reported at -$1.9 million in Q3 2025.

  • For Q3 2025, Gross Profit fell 18.26% year-over-year to -$1.9 million; the TTM value through Sep 2025 reached -$14.6 million, changed N/A, while the annual FY2024 figure was -$4.2 million, 323.97% down from the prior year.
  • Gross Profit reached -$1.9 million in Q3 2025 per UPB's latest filing, up from -$9.1 million in the prior quarter.
  • Across five years, Gross Profit topped out at $289000.0 in Q1 2024 and bottomed at -$9.1 million in Q2 2025.